208 related articles for article (PubMed ID: 36102903)
21. Chronic kidney disease-associated pruritus in patients undergoing hemodialysis: Xerosis and topical therapy.
Krismi A; Danarti R; Setiabudi IIDPP; Wirohadidjojo YW
Hemodial Int; 2023 Apr; 27(2):91-104. PubMed ID: 36811513
[TBL] [Abstract][Full Text] [Related]
22. Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program.
Fishbane S; Wen W; Munera C; Lin R; Bagal S; McCafferty K; Menzaghi F; Goncalves J
Kidney Med; 2022 Aug; 4(8):100513. PubMed ID: 36039153
[TBL] [Abstract][Full Text] [Related]
23. Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients.
Fishbane S; Mathur V; Germain MJ; Shirazian S; Bhaduri S; Munera C; Spencer RH; Menzaghi F;
Kidney Int Rep; 2020 May; 5(5):600-610. PubMed ID: 32405581
[TBL] [Abstract][Full Text] [Related]
24. Difelikefalin (Korsuva) for chronic kidney disease-associated pruritus.
Med Lett Drugs Ther; 2022 Feb; 64(1643):18-19. PubMed ID: 35134047
[No Abstract] [Full Text] [Related]
25. Recent advances in the treatment of uremic pruritus.
Trachtenberg AJ; Collister D; Rigatto C
Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):465-470. PubMed ID: 32740217
[TBL] [Abstract][Full Text] [Related]
26. Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.
Kim BS; Bissonnette R; Nograles K; Munera C; Shah N; Jebara A; Cirulli J; Goncalves J; Lebwohl M;
N Engl J Med; 2023 Feb; 388(6):511-517. PubMed ID: 36780675
[TBL] [Abstract][Full Text] [Related]
27. Pruritus in Hemodialysis Patients: Longitudinal Associations With Clinical and Patient-Reported Outcomes.
Sukul N; Zhao J; Pisoni RL; Walpen S; Schaufler T; Asgari E; Guebre-Egziabher F; Zho L; Abdulrahman Al-Ghonaim M; Nitta K; Robinson BM; Karaboyas A
Am J Kidney Dis; 2023 Dec; 82(6):666-676. PubMed ID: 37777951
[TBL] [Abstract][Full Text] [Related]
28. Kappa opioid agonists in the treatment of itch: just scratching the surface?
Beck TC; Wilson EM; Wilkes E; Lee LW; Norris R; Valdebran M
Itch (Phila); 2023; 8(4):. PubMed ID: 38099236
[TBL] [Abstract][Full Text] [Related]
29. [Not Available].
Azancot S; Ureña-Torres P; Chazot C; Touzot M
Nephrol Ther; 2022 Dec; 18(6S1):6S11-6S16. PubMed ID: 36585120
[TBL] [Abstract][Full Text] [Related]
30. [Pruritus associated with chronic kidney disease in hemodialysis patients: a survey in French nephrologists].
Touzot M; Bataille P; Rostoker G; Chauveau P; Lanot A; Misery L
Nephrol Ther; 2023 Nov; 19(6):475-482. PubMed ID: 37915193
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the physical dependence potential of difelikefalin: Randomized placebo-controlled study in patients receiving hemodialysis.
Spencer RH; Munera C; Shram MJ; Menzaghi F
Clin Transl Sci; 2023 Sep; 16(9):1559-1568. PubMed ID: 37128642
[TBL] [Abstract][Full Text] [Related]
32. Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double-blind, placebo-controlled trial.
Viscusi ER; Torjman MC; Munera CL; Stauffer JW; Setnik BS; Bagal SN
Clin Transl Sci; 2021 Sep; 14(5):1886-1893. PubMed ID: 33982405
[TBL] [Abstract][Full Text] [Related]
33. Chronic Kidney Disease-Associated Pruritus: A Review.
Makar M; Smyth B; Brennan F
Kidney Blood Press Res; 2021; 46(6):659-669. PubMed ID: 34515143
[TBL] [Abstract][Full Text] [Related]
34. Newer and Safer Kappa-Opioid Agonist for Your Patients With Uremic Pruritus.
Lagacé F; Jfri A; Litvinov IV; Netchiporouk E
J Cutan Med Surg; 2020; 24(5):525-526. PubMed ID: 32426990
[No Abstract] [Full Text] [Related]
35. Randomized controlled trial of nalfurafine for refractory pruritus in hemodialysis patients.
Zhang P; Xiang S; Liu B; Wang X; Yang X; Ye C; Wang Z; Li Y; Zhou L; Wang C; Li H; Huang J; Peng A; Wang X; Wang D; Xiao J; Chen W; Cheng H; Mao N; Wang J; Yang L; Chen J
Ren Fail; 2023 Dec; 45(1):2175590. PubMed ID: 36856148
[No Abstract] [Full Text] [Related]
36. Perception of Spanish nephrologists on an old unsolved problem: Pruritus associated with chronic kidney disease (CKD-aP).
Goicoechea M; Arenas-Jimenez MD; Areste N; Perez-Morales RE; Esteve V; Sanchez-Alvarez E; Alcalde Bezhold G; Blanco A; Sanchez-Villanueva R; Molina P; Ojeda R; Prieto-Velasco M; Manuel Buades J
Nefrologia (Engl Ed); 2023; 43(1):102-110. PubMed ID: 37069038
[TBL] [Abstract][Full Text] [Related]
37. Pathways for Diagnosing and Treating CKD-Associated Pruritus: A Narrative Review.
Rigatto C; Collister D; Granger-Vallée A; Girard L; Hingwala J; Karaboyas A; Levin A; McFarlane P; Pisoni R; Prasad B; Proulx N; Schwartz D; Sood M; Suri R; Tennankore K
Can J Kidney Health Dis; 2024; 11():20543581241238808. PubMed ID: 38680970
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, patient burden and physicians' perception of pruritus in haemodialysis patients.
Engler F; Kerschbaum J; Keller F; Mayer G;
Nephrol Dial Transplant; 2024 Jan; 39(2):277-285. PubMed ID: 37429597
[TBL] [Abstract][Full Text] [Related]
39. Pruritus in chronic kidney disease.
Uppal NN; Corona A; Fishbane S
Curr Opin Nephrol Hypertens; 2022 Sep; 31(5):435-441. PubMed ID: 35894277
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
